4//SEC Filing
Evanson Jeff 4
Accession 0001209191-21-071123
CIK 0001649989other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:32 PM ET
Size
5.7 KB
Accession
0001209191-21-071123
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-21+800,000→ 800,000 totalExercise: $1.44Exp: 2031-12-21→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 21, 2022, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001760511
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 5:32 PM ET
- Size
- 5.7 KB